2008 Volume 16 Issue 2 Pages 39-52
Daiichi Sankyo Co., Ltd. is one of the largest Japanese pharmaceutical companies, which was formed by business integration between Sankyo Co. and Daiichi Pharmaceutical Co. Under this business integration process, Daiichi Sankyo has established new management style and system, which is not always based on the former companies’ traditional ways of thinking. Daiichi Sankyo aims at realization of stimulating diversification with the new management style and system, which has several unique aspects. Primarily, Daiichi Sankyo aims to achieve corporate vision by utilizing the united style and system consistently from the top management to the bottom. Secondly, through the operation under its management style and system Daiichi Sankyo emphasizes on promoting self-directed innovation and unifies the group under management policies to improve organizational capabilities. Thirdly, Daiichi Sankyo aims to create corporate value continuously by the operation of Daiichi Sankyo’s unique twelve elements of a cycle of plan-do-check-action. Fourthly, the style and the system fulfill society’s various demands and social responsibilities as a member of the society by evaluation of business procedure from the point of each stakeholder’s view. At the same time the internal control is fulfilled by operation of the same style and system. Lastly, the staff is posted in various tiers of the organization to support management for optimization as the whole, resolution of issues, and risk management.
